Spinal Muscular Atrophy (SMA) is an autosomal recessive neuromuscular disease caused by loss of functional SMN1 gene copies, leading to progressive muscle weakness and motor neuron degeneration.
Indications: Why test SMN1 / SMN2?
Infants or children exhibiting hypotonia ("floppy baby"), motor delay, or weakness.
Pre-conception carrier screening for prospective parents.
Determining SMN2 copy number to assess eligibility for targeted gene therapies.
When should I take the test? At birth/infancy if symptomatic, or during pre-conception screening.
Do I need to fast or prepare?
No fasting or special preparation required.
Fields marked with the red asterisk (*) are mandatory
Test Summary Specs
Turnaround Time
7 to 10 Business Days
Estimated Cost
KES 25,000 – KES 35,000
Methodology
Targeted PCR / Sanger / NGS Variant Panel
Sample Type
5 mL Peripheral Whole Blood (EDTA), Buccal Swabs, or Prenatal Samples